NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

JNJ

Johnson & Johnson

Apr 17 • 04:00PM ET

157.47

Dollar change +3.56
Percentage change 2.31	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK PFE NVS AMGN BMY LLY GSK ABT MDT SYK

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM VHT IWD

Scroll to Statements

Index	DJIA, S&P 500	P/E	17.50	EPS (ttm)	9.00	Insider Own	0.13%	Shs Outstand	2.41B	Perf Week	5.90%
Market Cap	379.48B	Forward P/E	14.24	EPS next Y	11.06	Insider Trans	-0.62%	Shs Float	2.41B	Perf Month	-3.39%
Income	21.81B	PEG	3.09	EPS next Q	2.67	Inst Own	73.05%	Short Float	0.80%	Perf Quarter	6.56%
Sales	89.33B	P/S	4.25	EPS this Y	5.99%	Inst Trans	0.72%	Short Ratio	1.88	Perf Half Y	-4.04%
Book/sh	29.70	P/B	5.30	EPS next Y	4.53%	ROA	8.09%	Short Interest	19.15M	Perf Year	9.01%
Cash/sh	10.18	P/C	15.48	EPS next 5Y	5.66%	ROE	20.06%	52W Range	140.68 - 169.99	Perf YTD	8.89%
Dividend Est.	4.94 (3.14%)	P/FCF	19.13	EPS past 5Y	0.55%	ROI	21.10%	52W High	-7.37%	Beta	0.43
Dividend TTM	4.96 (3.15%)	Quick Ratio	0.86	Sales past 5Y	2.03%	Gross Margin	75.56%	52W Low	11.93%	ATR (14)	4.43
Dividend Ex-Date	Feb 18, 2025	Current Ratio	1.11	EPS Y/Y TTM	3.69%	Oper. Margin	23.72%	RSI (14)	51.19	Volatility	2.71% 2.74%
Employees	138100	Debt/Eq	0.53	Sales Y/Y TTM	-0.37%	Profit Margin	24.42%	Recom	2.17	Target Price	170.61
Option/Short	Yes / Yes	LT Debt/Eq	0.45	EPS Q/Q	238.80%	Payout	84.80%	Rel Volume	1.08	Prev Close	153.91
Sales Surprise	1.55%	EPS Surprise	7.33%	Sales Q/Q	2.39%	Earnings	Apr 15 BMO	Avg Volume	10.19M	Price	157.47
SMA20	0.45%	SMA50	-1.37%	SMA200	0.46%	Trades		Volume	10,971,376	Change	2.31%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185

Show Previous Ratings

Apr-19-25 09:01PM	From $50 A Month To $1M Portfolio Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline (Benzinga)
11:42AM	Johnson & Johnson (JNJ): Among Value Stocks in Ken Fisher's Portfolio (Insider Monkey)
10:30AM	3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now (Motley Fool)
05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
01:25AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 20 (Seeking Alpha)
03:08PM	Loading…
Apr-18-25 03:08PM	Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy (Insider Monkey)
07:00AM	Johnson & Johnson Pivots Its AI Strategy (The Wall Street Journal)
Apr-17-25 10:01PM	How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock (Benzinga)
10:51AM	Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
09:15AM	Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback (Zacks)
08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
08:05AM	Why Most Dividend Retirement Strategies Fail: How To Retire With Dividends (Seeking Alpha)
08:03AM	Here's How You Should Play JNJ Stock After Q1 Earnings Beat (Zacks)
07:05AM	Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valleys version of Johnson & Johnson (Fortune)
06:20AM	Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar? (Zacks)
04:51AM	Loading…
04:51AM	4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market (Motley Fool)
04:07AM	This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row (Motley Fool)
Apr-16-25 06:35PM	Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ (Zacks)
04:28PM	Analyst Report: Johnson & Johnson (Morningstar Research)
04:28PM	Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference (Business Wire)
02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
12:28PM	J&Js electrophysiology sales dip amid slow Varipulse start (MedTech Dive)
11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks)
11:24AM	Needham upgrades Boston Scientific on easing competition, growth opportunities (Investing.com)
11:19AM	Is Johnson & Johnson (JNJ) the Best Dividend Monarch to Invest in Now? (Insider Monkey)
10:00AM	ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike (Zacks)
09:31AM	Jim Cramer: Johnson & Johnson (JNJ) Is a "Great American Company with a AAA Balance Sheet" (Insider Monkey)
07:58AM	Johnson & Johnson Earnings Were More Good Than Bad-Time to Buy? (MarketBeat)
03:00AM	Johnson & Johnson (JNJ) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid STELARA ... (GuruFocus.com)
01:26AM	Q1 2025 Johnson & Johnson Earnings Call (Thomson Reuters StreetEvents)
10:15PM	Loading…
Apr-15-25 10:15PM	Zeroes Across The Board (Seeking Alpha)
04:44PM	Stocks fizzle after two-day rally driven by bank earnings and tech (Quartz)
04:42PM	These Stocks Moved the Most Today: Bank of America, Citigroup, Netflix, Boeing, Tesla, HPE, Applied Digital, and More (Barrons.com)
03:49PM	J&J expects a $400M hit from tariffs, mostly from China (Yahoo Finance Video)
03:26PM	J&J Forecasts $400 Million in Tariff-Related Costs This Year (The Wall Street Journal)
03:06PM	These Stocks Are Moving the Most Today: Bank of America, Citigroup, Netflix, Boeing, Tesla, HPE, Applied Digital, and More (Barrons.com)
03:01PM	Johnson & Johnson (JNJ): Stuck in a Range but Ready to Break Out if Legal Clouds Clear - Jim Cramer Weighs In (Insider Monkey)
03:00PM	Two New Dividend Picks To Help You Navigate Tariffs And Uncertainty -- One Yields 7%+ (Seeking Alpha)
02:40PM	J&J projects $400m tariff hit but raises sales outlook (Pharmaceutical Technology)
01:20PM	Wall Street Lunch: Banks Liking These Market Swings (Seeking Alpha)
12:42PM	Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript (Seeking Alpha)
12:07PM	Analyst Report: Johnson & Johnson (Morningstar Research)
12:05PM	J&J beat on earnings, but tariffs still pressure pharma sector (Yahoo Finance Video)
11:53AM	Johnson & Johnson beats on top and bottom lines (CNBC TV)
11:51AM	J&J sees tariff impact from exports to China more than global imports: CFO (Yahoo Finance)
11:20AM	Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China (Associated Press Finance)
11:15AM	Citi and BofA earnings, Johnson & Johnson, China blocks Boeing (Yahoo Finance Video)
11:14AM	JNJ Tops Q1 Earnings, Ups '25 Sales View to Include Intra-Cellular Deal (Zacks)
11:04AM	J&J Increases Outlook After Beating 1Q Expectations (The Wall Street Journal)
11:04AM	Import Prices Turn Negative for First Time Since September (Zacks)
10:54AM	Why Johnson & Johnson Stock Is Down After Earnings Beat Expectations (Barrons.com)
10:53AM	Cramer's Stop Trading: Johnson & Johnson (CNBC TV)
10:51AM	J&J Expects Tariffs to Cost Company $400 Million (Bloomberg)
10:43AM	Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves (Seeking Alpha)
10:42AM	Stock Market Today: Dow Jones Climbs While S&P 500 Flashes This Warning; These Bank Names Rally On Earnings (Live Coverage) (Investor's Business Daily)
10:19AM	Import Prices, Empire State Come In Mild; Q1 Earnings Beats Abound (Zacks)
09:47AM	Johnson & Johnson Raises Sales Outlook as Pharma Sales Lead Q1 Beat (GuruFocus.com)
09:30AM	Compared to Estimates, Johnson & Johnson (JNJ) Q1 Earnings: A Look at Key Metrics (Zacks)
09:09AM	Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit (Benzinga)
08:57AM	2 Under-the-Radar Consumer Staples Stocks With Big Dividends (MarketBeat)
08:55AM	NYSE Content Advisory: Pre-Market update + Bank of America beats earnings estimates (PR Newswire)
08:49AM	Johnson & Johnson Skids Despite First-Quarter Beat, Sales Guidance Hike (Investor's Business Daily)
08:49AM	J&J Flexes Its Financial 'Bicep,' Hiking Guidance Despite Tariff Headwinds (Investor's Business Daily)
08:44AM	Bank of America, Citigroup, Johnson & Johnson: Stocks to watch today (Quartz)
08:08AM	Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke (TipRanks)
07:54AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:52AM	Johnson & Johnson Tops Earnings Estimates and Boosts Outlook. The Stock Slips. (Barrons.com)
07:52AM	Johnson & Johnson CFO on earnings: Guidance has 'a lot more than meets the eye' (CNBC TV)
07:35AM	Johnson & Johnson (JNJ) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:22AM	Can ISRG Stock Revive its Growth Momentum After the Sudden Slide? (Zacks)
07:14AM	S&P 500 Futures Steady as Trade War Nerves Ease: Markets Wrap (Bloomberg)
06:35AM	Johnson & Johnson Tops Q1 Estimates, Lifts Full-Year Sales Outlook (Investopedia)
06:32AM	Johnson & Johnson's (NYSE:JNJ) Q1 Sales Top Estimates, Full-Year Sales Guidance is Optimistic (StockStory)
06:29AM	Johnson & Johnson: Q1 Earnings Snapshot (Associated Press Finance)
06:25AM	Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8% (Business Wire)
06:23AM	J&J earnings beat estimates on strong cancer drug sales (Reuters)
06:20AM	Johnson & Johnson Reports Q1 2025 Results (Business Wire)
Apr-14-25 11:32PM	Trump Initiates Chips and Drug Probes Ahead of More Tariffs (Bloomberg)
07:00PM	Big Bank earnings, Fed commentary, tax deadline: What to Watch (Yahoo Finance Video)
05:44PM	Pfizer hits setback in obesity drug race as GLP-1 trial halts (Yahoo Finance Video)
04:44PM	Johnson & Johnson Is Beating the Market. Legal Troubles Continue as Earnings Arrive. (Barrons.com)
12:17PM	Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect (StockStory)
09:50AM	Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds? (Insider Monkey)
03:22AM	JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview (Zacks)
02:30AM	Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains? (Zacks)
Apr-13-25 05:41PM	Why Johnson & Johnson (JNJ) is the Best Medical Stock to Buy According to Billionaires (Insider Monkey)
05:29PM	Wall Street Brunch: Tariffs For Some (Seeking Alpha)
02:12PM	DJD: Dividend And Value In Mega Caps (Seeking Alpha)
09:37AM	Wall Street Week Ahead (Seeking Alpha)
08:01AM	Navigating Today's Volatile Market: A Stress-Free Approach (Seeking Alpha)
06:00AM	What To Expect in the Markets This Week (Investopedia)
Apr-12-25 11:00AM	Goldman Sachs, J&J, To Report Earnings As Investors Watch Out For Retail Sales Data (Seeking Alpha)
09:05AM	Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds? (Insider Monkey)
08:30AM	How To Buy Low And Sell High Consistently For Lifelong Wealth (Seeking Alpha)
Apr-11-25 01:59PM	Jim Cramer on Johnson & Johnson (JNJ): AAA Balance Sheet… An Unjustified Casualty of Pharma Tariffs (Insider Monkey)
12:46PM	Johnson & Johnson: Fairly Valued, But Recession-Resilient (Seeking Alpha)
12:45PM	IGD: Capital Erosion And Shrinking Dividend Payouts (Seeking Alpha)
11:32AM	Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings (Zacks)
07:41AM	J&J reports analysis from Phase III trial of plaque psoriasis treatment (Clinical Trials Arena)
06:20AM	Is First Trust Dow 30 Equal Weight ETF (EDOW) a Strong ETF Right Now? (Zacks)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Decker Robert J	VP Corporate Controller	Feb 25 '25	Option Exercise	101.87	6,999	712,988	28,000	Feb 26 06:42 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Sale	165.88	6,999	1,160,994	21,001	Feb 26 06:42 PM
Decker Robert J	Officer	Feb 25 '25	Proposed Sale	165.88	6,999	1,161,010		Feb 25 03:05 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	2,806	0	17,904	Feb 18 09:46 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '25	Option Exercise	0.00	1,029	0	15,501	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	1,765	0	15,111	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '25	Option Exercise	0.00	499	0	13,539	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '25	Sale	156.15	403	62,928	15,098	Feb 18 09:33 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '25	Option Exercise	0.00	607	0	91,037	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 14 '25	Option Exercise	0.00	7,367	0	96,674	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '25	Option Exercise	0.00	651	0	89,603	Feb 18 09:16 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '25	Option Exercise	0.00	1,971	0	6,113	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 14 '25	Option Exercise	0.00	19,330	0	20,661	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '25	Option Exercise	0.00	1,779	0	1,779	Feb 18 09:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '25	Option Exercise	0.00	1,350	0	15,927	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '25	Option Exercise	0.00	1,594	0	171,110	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 14 '25	Option Exercise	0.00	19,518	0	185,924	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '25	Option Exercise	0.00	1,302	0	167,221	Feb 18 09:08 PM
Swanson James D.	EVP, CIO	Feb 15 '25	Option Exercise	0.00	492	0	16,762	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 14 '25	Option Exercise	0.00	5,079	0	19,739	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 13 '25	Option Exercise	0.00	447	0	15,019	Feb 18 09:06 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '25	Option Exercise	0.00	419	0	13,095	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	2,608	0	14,576	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '25	Option Exercise	0.00	411	0	12,100	Feb 18 09:05 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 15 '25	Option Exercise	0.00	961	0	10,321	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 14 '25	Option Exercise	0.00	2,203	0	11,366	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '25	Option Exercise	0.00	651	0	8,991	Feb 18 09:03 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '25	Option Exercise	0.00	3,682	0	397,525	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 14 '25	Option Exercise	0.00	24,335	0	415,205	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '25	Option Exercise	0.00	3,470	0	392,498	Feb 18 09:02 PM
Decker Robert J	VP Corporate Controller	Feb 15 '25	Option Exercise	0.00	339	0	20,116	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 14 '25	Option Exercise	0.00	2,201	0	21,373	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 13 '25	Option Exercise	0.00	312	0	19,285	Feb 18 09:01 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '25	Option Exercise	0.00	492	0	21,839	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 14 '25	Option Exercise	0.00	4,740	0	24,591	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '25	Option Exercise	0.00	408	0	20,242	Feb 18 08:58 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 07 '25	Option Exercise	100.06	126,369	12,644,482	489,671	Feb 11 07:43 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 07 '25	Option Exercise	100.06	32,762	3,278,166	115,028	Feb 11 07:42 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 07 '25	Option Exercise	100.06	58,504	5,853,910	213,355	Feb 11 07:41 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Option Exercise	100.06	13,015	1,302,281	13,015	Feb 11 07:40 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Sale	153.89	13,015	2,002,878	0	Feb 11 07:40 PM
Wolk Joseph J	Officer	Feb 07 '25	Proposed Sale	153.89	13,015	2,002,924		Feb 07 01:27 PM
WEINBERGER MARK A	Director	Dec 12 '24	Buy	147.22	1,000	147,220	1,000	Dec 12 05:27 PM
Hait William	Former Officer	Dec 04 '24	Proposed Sale	149.90	25,742	3,858,598		Dec 04 01:25 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Option Exercise	100.06	5,635	563,838	24,608	Sep 03 04:48 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Sale	165.06	5,635	930,113	18,973	Sep 03 04:48 PM
Decker Robert J	Officer	Aug 30 '24	Proposed Sale	165.06	5,635	930,113		Aug 30 03:51 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 08 '24	Option Exercise	0.00	9,809	0	24,852	Jul 09 05:48 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '24	Option Exercise	0.00	22,255	0	22,561	May 03 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience